TScan Therapeutics, Inc. (NASDAQ:TCRX – Get Rating) – Stock analysts at HC Wainwright cut their Q2 2023 earnings estimates for TScan Therapeutics in a research note issued to investors on Thursday, May 11th. HC Wainwright analyst A. Fein now forecasts that the company will post earnings of ($1.04) per share for the quarter, down from […]
At 8 7% CAGR, Dermatological Therapeutics Market Size, Growth and Share to accumulate over $ 100 million by 2025 marketwatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketwatch.com Daily Mail and Mail on Sunday newspapers.